Gangliosid GD2 als Zielstruktur für neue Kombinationstherapien mit chimären T-Zell-Rezeptoren bei Ewing-Sarkomeren

Basic data for this project

Type of projectIndividual project
Duration at the University of Münster01/04/2014 - 31/03/2017

Description

KeywordsEwing-Sarkomere
Funding identifierRO2402/6-1
Funder / funding scheme
  • DFG - Individual Grants Programme

Project management at the University of Münster

Rössig, Claudia
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)

Applicants from the University of Münster

Rössig, Claudia
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)